SNCA and Parkinson disease: Parkinson's disease (PD) is a neurodegenerative disorder defined by dopaminergic neuronal loss in the substantia nigra (SN) pars compacta, aggregation of misfolded α-synuclein (α-syn) as Lewy bodies, and motor dysfunction (Trudler et al., 2015).